This is not a rigorous treatise on proposal writing or Grantsmanship 101.
- Commercialization Support
- Writing Tips
- Success Rates
- SBIR/STTR Benefits
- Lean Startup
- Agency Specific
- SBIR Support
- Client Success
- Our Team
- Investments
- Budget
- Ideadvance Seed Fund
- Business Impact
- UW System
- WEDC
- Awards
- SBA
- SBIR
- SBIR Advance
- ForwardWERX
- CTC Sparks
- SBIR Ready
- Wisconsin Tech Council
- Edible-Alpha
- News
- Economic Development
- Events
- Go Global
- Workforce
- FAST
Dave Linz, MBA, MS
Where/How to start writing your SBIR/STTR Proposal
Ok relax and breathe. 1. Read through the solicitation and proposal preparation instructions quickly.
DOD Opportunities for SBIR and other Research Funding.
Wisconsin has some of the best success rates in the country for NIH and NSF SBIR awards (see 2019 articles NIH & NSF), and Wisconsin has multiple large DOD contractors that are manufacturing strategically important military equipment.
An Afternoon with the FDA – Webinar Recap
The National Institutes of Health (NIH) Commercialization Accelerator Program (CAP) [NIH CAP], Larta Institute, and the Food & Drug Administration (FDA) presented “An FDA Afternoon” online webinar on March 31.
Top 10 Reasons to Pursue SBIR/STTR
There are many reasons to consider tapping America’s Seed Fund to fund your business.
Will it work? What is Feasibility?
Feasibility is often a loosely defined term that might be difficult to pin down.
Make beginning a 1st draft less daunting with these simple steps
Don’t know where to start?? Follow our guide to building the first draft of your SBIR proposal.
Is SBIR/STTR a Fit for Me? Take the T.E.S.T
Is SBIR/STTR a Fit for Me? Take the T.E.S.T Here is a simple test with some Go – No Go criteria to see if SBIR/STTR is a fit for your company.
Let’s Talk Significance!
Your SBIR proposal must communicate strong significance, but many proposals I review fall short in this area.
Strategies from Research to Commercialization; Commercialization Support Programs
We often hear from entrepreneurs about the challenges in acquiring additional funds to further de-risk technologies and navigate through the dreaded Valley of Death.